Lars Lengquist – Page 3

Seminar – Almedalen ”No precision medicine without pathology”

Stratipath Breast AI-based risk profiling for breast cancer is now available for clinical use in the UK.

Stratipath Breast, is now officially registered with the Medicines and Healthcare products Regulatory Agency (MHRA). This registration allows healthcare providers across the United Kingdom access to the AI-based prognostic tool for breast cancer risk profiling.

Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine

Stratipath is the winner of the Health Tech Award 2024 at Vitalis!

Interview with Stratipath CTO Mattias Rantalainen about SwAIPP

Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP (Sweden AI Precision Pathology), is being interviewed by Vinnova regarding innovation in precision medicine. “For us, building evidence around the solutions we develop is important. We collaborate internationally in several ongoing validation studies. We also gain synergies by conducting overlapping activities with a Nordic consortium. […]

MedTechLabs labs interview with Stratipath CEO, Fredrik Wetterhall,

MedTechLabs labs recently interviewed our CEO, Fredrik Wetterhall, discussing the rapid development from research to clinical use and the future trajectory of Stratipath.

Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”

Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”.

”Inside Pathology” by Paige features Stratipath co-workers

Stratipath is now a part of Paige AppLab

Stratipath and Proscia Partnership Spotlighted in Pathology News

Author: Lars Lengquist